BEHAVIORAL PHARMACOLOGY OF CANNABIS
Clinical trials for BEHAVIORAL PHARMACOLOGY OF CANNABIS explained in plain language.
Never miss a new study
Get alerted when new BEHAVIORAL PHARMACOLOGY OF CANNABIS trials appear
Sign up with your email to follow new studies for BEHAVIORAL PHARMACOLOGY OF CANNABIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cannabis compound sharpen or dull the mind? a study puts CBG to the test
Knowledge-focused CompletedThis trial investigates how a single oral dose of cannabigerol (CBG), a natural compound from the cannabis plant, affects healthy adults. Over five sessions, participants receive either a placebo or one of four doses of CBG, then undergo eight hours of monitoring including blood …
Matched conditions: BEHAVIORAL PHARMACOLOGY OF CANNABIS
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Delta-8 vs Delta-9: which THC is stronger?
Knowledge-focused CompletedThis study looked at how Delta-8 THC, a compound similar to the main psychoactive ingredient in cannabis, affects people compared to Delta-9 THC and a placebo. 28 healthy adults took the substances by mouth or by inhalation. Researchers measured their mood, thinking skills, and c…
Matched conditions: BEHAVIORAL PHARMACOLOGY OF CANNABIS
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC